Variant report
Variant | esv3350961 |
---|---|
Chromosome Location | chr10:1695703-1695885 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs78254650 | chr10:1695703-1695704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs199771726 | chr10:1695726-1695727 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs117896715 | chr10:1695729-1695730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562737856 | chr10:1695731-1695732 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs117389972 | chr10:1695734-1695735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557044346 | chr10:1695735-1695736 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs114786282 | chr10:1695740-1695741 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10903537 | chr10:1695751-1695752 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs10903538 | chr10:1695756-1695757 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536466872 | chr10:1695760-1695761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs114324639 | chr10:1695763-1695764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
12 | rs376155068 | chr10:1695764-1695765 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201707434 | chr10:1695772-1695773 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550049049 | chr10:1695801-1695802 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569823098 | chr10:1695803-1695804 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73587121 | chr10:1695804-1695805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111638390 | chr10:1695805-1695806 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535558073 | chr10:1695814-1695815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs12767490 | chr10:1695825-1695826 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs12767498 | chr10:1695830-1695831 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs534645558 | chr10:1695841-1695842 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs370669406 | chr10:1695878-1695879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 20409316 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Cancer | 21129771 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Wilms tumour | 19047088 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Barakat syndrome | 22470819 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Autism | 18414403 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Breast cancer | 22032731 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 17363583 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21785460 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Autism | 22543975 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:1688800-1697200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr10:1689200-1700000 | Weak transcription | Brain Substantia Nigra | brain |
3 | chr10:1691400-1697000 | Weak transcription | GM12878-XiMat | blood |
4 | chr10:1693600-1698400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr10:1695200-1697400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr10:1695200-1700600 | Weak transcription | Brain Cingulate Gyrus | brain |
7 | chr10:1695200-1700800 | Weak transcription | Fetal Brain Female | brain |
8 | chr10:1695200-1704000 | Weak transcription | Spleen | Spleen |
9 | chr10:1695400-1712000 | Weak transcription | Gastric | stomach |